VERA Vera Therapeutics Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: VERA

Price (delayed)

$33.05

Market cap

$2.38B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$5.86

Enterprise value

$2.41B

?
Relative Growth: Rel. Growth: 2
Relative Strength: Rel. Strength: 29
Relative Valuation: Rel. Valuation: N/A
Relative Profitability: Rel. Profitability: 2
Highlights
VERA's debt is down by 3% year-on-year
The net income has plunged by 84% YoY and by 9% from the previous quarter
VERA's EPS has dropped by 64% year-on-year and by 6% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://veratx.com
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of VERA

VERA stock price

How has the Vera Therapeutics stock price performed over time
Intraday
-8.85%
1 week
4.03%
1 month
2.4%
1 year
27.31%
YTD
-34.74%
QTD
-22.98%

Financial performance

How have Vera Therapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$415.76M
Net income
-$401.9M
Gross margin
N/A
Net margin
N/A
The net income has plunged by 84% YoY and by 9% from the previous quarter
VERA's operating income has dropped by 76% year-on-year and by 8% since the previous quarter

Price vs fundamentals

How does VERA's price correlate with its fundamentals

Growth

What is Vera Therapeutics's growth rate over time

Valuation

What is Vera Therapeutics stock price valuation
P/E
N/A
P/B
5.82
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VERA's EPS has dropped by 64% year-on-year and by 6% since the previous quarter
VERA's P/B is 20% more than its 5-year quarterly average of 5.3 and 10% more than its last 4 quarters average of 5.8
VERA's equity is down by 18% since the previous quarter and by 13% year-on-year

Efficiency

How efficient is Vera Therapeutics business performance
The ROIC has plunged by 104% YoY and by 13% from the previous quarter
VERA's return on equity has dropped by 80% year-on-year and by 12% since the previous quarter
The ROA has dropped by 69% year-on-year and by 11% since the previous quarter

Dividends

What is VERA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for VERA.

Financial health

How did Vera Therapeutics financials performed over time
The quick ratio has contracted by 38% YoY and by 22% from the previous quarter
The company's current ratio fell by 36% YoY and by 20% QoQ
VERA's debt is 82% smaller than its equity
Vera Therapeutics's debt to equity has increased by 20% QoQ and by 6% YoY
VERA's equity is down by 18% since the previous quarter and by 13% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.